Healthcare Stocks Among Worst Performers -- Healthcare Roundup

Dow Jones

Apr 16, 2025

Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2.

Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies.

J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs.

Write to Paulo Trevisani at paulo.trevisani@wsj.com

(END) Dow Jones Newswires

April 15, 2025 17:01 ET (21:01 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2527047808"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2527047808\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2527047808?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-16 05:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2527047808","market":"fut","top_or_hot":-1,"title":"Healthcare Stocks Among Worst Performers -- Healthcare Roundup","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n</p>\n<p>\n  Johnson &amp; Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n</p>\n<p>\n  J&amp;J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 15, 2025 17:01 ET (21:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Healthcare Stocks Among Worst Performers -- Healthcare Roundup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHealthcare Stocks Among Worst Performers -- Healthcare Roundup\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-04-16 05:01</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n  Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n</p>\n<p>\n  Johnson &amp; Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n</p>\n<p>\n  J&amp;J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 15, 2025 17:01 ET (21:01 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4137","symbol_name":"综合支持服务","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2527047808","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2527047808","pubTimestamp":1744750860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2.Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies.J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4137":"综合支持服务","HCSG":"Healthcare Svcs Group Inc"},"translate_title":"医疗保健股是表现最差的股票之一——医疗保健综述","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HCSG":1},"content_text":"Healthcare shares were among the worst performers Tuesday, as Wall Street paused from its recent volatility. The market had seen dramatic swings since President Trump's tariff announcement on April 2. \n\n\n  Johnson & Johnson exceeded expectations for first-quarter earnings and revenue, raising its full-year sales outlook due to acquisition of drug developer Intra-Cellular Therapies. \n\n\n  J&J's 1Q report bodes well for the medical-technology sector, JPMorgan analysts said in a research note, citing the company's positive commentary on overall demand and preliminary thoughts on tariffs. \n\n\n \n\n\n  Write to Paulo Trevisani at paulo.trevisani@wsj.com \n\n\n  (END) Dow Jones Newswires\n\n\n  April 15, 2025 17:01 ET (21:01 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}